Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tami Grunewald"'
Autor:
Hanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, Ayse U. Akarca, Yeman Hagos, Faranak Sobhani, Catherine S.Y. Lecat, Dominic Patel, Lydia Lee, Manuel Rodriguez-Justo, Kwee Yong, Jonathan A. Ledermann, John Le Quesne, E. Shelley Hwang, Teresa Marafioti, Yinyin Yuan
Publikováno v:
EBioMedicine, Vol 95, Iss , Pp 104769- (2023)
Summary: Background: Efficient biomarker discovery and clinical translation depend on the fast and accurate analytical output from crucial technologies such as multiplex imaging. However, reliable cell classification often requires extensive annotati
Externí odkaz:
https://doaj.org/article/247dba90151c4cdeb67c905958d7c6d9
Autor:
Hanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, Ayse Akarca, Yeman Hagos, Faranak Sobhani, Catherine Lecat, Dominic Patel, Lydia Lee, Manuel Rodriguez-Justo, Kwee Yong, Jonathan A. Ledermann, John Le Quesne, E. Shelley Hwang, Teresa Marafioti, Yinyin Yuan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17d9be60cc3b1f4cd772c19ad35c7c56
https://doi.org/10.2139/ssrn.4359713
https://doi.org/10.2139/ssrn.4359713
Autor:
Hanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, Ayse Akarca, Yeman Hagos, Catherine Lecat, Dominic Pate, Lydia Lee, Manuel Rodriguez-Justo, Kwee Yong, Jonathan Ledermann, John Le Quesne, Teresa Marafioti, Yinyin Yuan
Publikováno v:
Resource-Efficient Medical Image Analysis ISBN: 9783031168758
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4710a255a11236364905c75c4a35e5b2
https://doi.org/10.1007/978-3-031-16876-5_2
https://doi.org/10.1007/978-3-031-16876-5_2
Autor:
Tami Grunewald, Kenrick Ng, Ernese Gjafa, Myria Galazi, Peter Wilson, Erik Skyllberg, Jonathan Shamash, Constantine Alifrangis
Publikováno v:
BJU internationalReferences. 127(2)
BACKGROUND: Bleomycin, Etoposide and Cisplatin (BEP) chemotherapy is the conventional treatment regimen for patients with germ cell tumours. The regimen is highly emetogenic and immunosuppressive. High dose steroids are often prescribed with this reg
Autor:
Tami Grunewald, Jonathan A. Ledermann
Publikováno v:
Best practiceresearch. Clinical obstetricsgynaecology. 41
Epithelial ovarian cancer has the highest mortality rate of all gynaecological malignancies. Most women present with advanced disease and develop a recurrence after radical surgery and chemotherapy. Improving the results of first- or subsequent-line
Autor:
Christian Schauer, Val Gebski, Giovanni Scambia, Tami Grunewald, Mark Heywood, Kathrine Woie, Philipp Harter, Michael Friedlander, Ignace Vergote, Annamaria Ferrero, Eric Pujade-Lauraine, Jalid Sehouli, Sarah J. Lord, Chee Khoon Lee, Anne-Claire Hardy-Bessard
The role of secondary cytoreductive surgery (SCR) in platinum-sensitive recurrent ovarian cancer (ROC) remains controversial. The overall survival (OS) benefits for surgery reported in observational studies may be due to the selection of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a5c1309d0d1950ff3b41265c75891e
https://hdl.handle.net/2318/1904354
https://hdl.handle.net/2318/1904354
Autor:
Kin Woo, Jonathan A. Ledermann, Arran Speirs, Miriam Mitchison, Tim De Meyer, Rebecca Kristeleit, Martin Forster, Michael John Devlin, Tami Grunewald, Mary McCormack, Michelle Lockley, Nicholas S. Brown, Rowan Miller
Publikováno v:
Cancer Research. 77:2726-2726
Background: Patients (pts) with advanced gynecological (GYN) cancers have limited therapeutic options and the prognosis is poor. Early phase trials may be a suitable option for pts with good performance status. Increasingly, molecular characterisatio
Autor:
Michael-John Devlin, Tami Grunewald, Mary McCormack, Nicholas F. Brown, Martin Forster, Jonathan A. Ledermann, R.E. Miller, Tim Meyer, Rebecca Kristeleit, Michelle Lockley
Publikováno v:
Journal of Clinical Oncology. 35:5597-5597
5597 Background: Patients (pts) with advanced endometrial (EC), cervical and vulval (CVC) cancer have limited therapeutic options and poor prognosis. Early phase trials may be a suitable option for pts with good performance status aided by molecular
Publikováno v:
Journal of Clinical Oncology. 34:5559-5559
5559Background: There has been little change in the outcome of patients with PROC over the last 20 years despite large numbers of patients entered on clinical trials. We examined the design and res...